Some were retired for convenience while others never made much sense, these are the old-school lawn and garden tools you ...

If students are to succeed and be employable, they must learn to be AI fluent. But fluency includes responsibility and there isn't much literature out there to draw from, so Associate Professor Pat ...

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Vertex executives warned that Casgevy, its ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

CHARLESTON, S.C. (WCSC) — A newly opened sickle cell treatment center at the Medical University of South Carolina is facing growing criticism from patients and civil rights advocates who say they are ...

RICHMOND, Va. — With the next General Assembly session set to begin next week, people who suffer from sickle cell anemia and their loved ones are gearing up to push for legislation and funding support ...

NASHVILLE, Tenn. (Ivanhoe Newswire) - Sickle cell disease is a devastating, inherited blood disorder that affects an estimated eight million people worldwide and roughly 100,000 here in the United ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine A new chapter is unfolding for patients with sickle cell ...

In its mission to grow the reach of its pyruvate kinase (PK) activator Pyrukynd (mitapivat), Agios Pharmaceuticals has come up short of producing an unequivocal win in the key indication of sickle ...